India, Jan. 15 -- The shares of this pharma stock, engaged in the manufacturing and exporting of API's and Nutraceutical ingredients, are in focus after leading global brokerage, CITI, has expressed its bullishness over the business, citing numerous upticks. In this article, we will dive more into the details.

With a market capitalisation of Rs 1,68,586 crore, the shares of Divis Laboratories Ltd closed at Rs 6,350.50 per share, down by 1.3 percent from its previous day's closing price of Rs 6,433.70 per share. Over the past five years, the stock has delivered a return of 74 percent, almost similar to NIFTY 50's return of 78 percent.

Analyst Comments Leading global brokerage, CITI, has assigned a Buy call on Divis Laboratories and has f...